Skip to main content
Year archive

Lee's Pharmaceutical Holdings Limited — 2020 filings

All 80 regulatory filings released by Lee's Pharmaceutical Holdings Limited (950) in 2020, sourced directly from the official regulator.

80 Filings
2020 Period
2020 filings (80)
Filing Released Lang
Voluntary Announcement - Update on Research and Development of an Investigational Ophthalmology Product of an Associated Company of the Group
Capital/Financing Update
2020-12-29 English
Proposed Spin-off and Separate Listing of Zhaoke Ophthalmology Limited on The Main Board of The Stock Exchange
Capital/Financing Update
2020-12-18 English
Voluntary Announcement - Trazodone Hydrochloride Tablet Obtained Drug Registration Certificate from China's National Medical Products Administration
Regulatory Filings
2020-12-11 English
Third Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
Capital/Financing Update
2020-12-01 English
Voluntary Announcement - Update on Research and Development of an Investigational Ophthalmology Product of an Associated Company of the Group
Regulatory Filings
2020-11-30 English
Third Quarterly Results Announcement for the Nine Months Ended 30 September 2020
Interim / Quarterly Report 9M 2020
2020-11-26 English
Voluntary Announcement - Update on the Possible Spin-Off and Separate Listing of Zhaoke Ophthalmology Limited
Capital/Financing Update
2020-11-20 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-11-18 English
Voluntary Announcement - Completion of Series B Shares Subscription in an Associated Company
Capital/Financing Update
2020-11-17 English
Voluntary Announcement - Business Update on the In-Licensing and Research and Development of Ophthalmology Products of an Associated Company of the Group
Regulatory Filings
2020-11-16 English
Notice of Board Meeting
Regulatory Filings
2020-11-16 English
Voluntary Announcement - Update on an Investigational Anaesthesia Product
Regulatory Filings
2020-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Share Issue/Capital Change
2020-11-02 English
Grant of Share Options
Share Issue/Capital Change
2020-10-23 English
Voluntary Announcement - Establishment of the Group Commercial Operations Centre
Board/Management Information
2020-10-23 English
Voluntary Announcement - Business Update on the In-Licensing and Research and Development of Ophthalmology Products of an Associated Company of the Group
Regulatory Filings
2020-10-20 English
Voluntary Announcement - Reduction in Equity Interest in an Associated Company
Capital/Financing Update
2020-10-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
Share Issue/Capital Change
2020-10-05 English
Discloseable Transaction - License Agreement in relation to Licensed Rights and Disposal of Equity Interest in a Subsidiary
Regulatory Filings
2020-10-04 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-09-25 English
Interim Report 2020
Interim / Quarterly Report H1 2020
2020-09-11 English
Voluntary Announcement - Update on an Investigational Inhaled Antipsychotic Product
Regulatory Filings
2020-09-03 English
Voluntary Announcement - Update on the Possible Spin-off and Separate Listing of China Ophthalmology Focus Limited
Capital/Financing Update
2020-09-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
Regulatory Filings
2020-09-01 English
Voluntary Announcement - Update on an Investigational Anaesthesia Product
Regulatory Filings
2020-08-31 English
Forfeiture of Unclaimed Dividends
Notice of Dividend Amount
2020-08-28 English
Interim Results for the Six Months Ended 30 June 2020
Interim / Quarterly Report H1 2020
2020-08-27 English
Voluntary Announcement - Update on the Introduction and Research and Development of an Investigational Oncology Product
Regulatory Filings
2020-08-21 English
Supplemental Announcement regarding Annual Report for the year ended 31 December 2019
Regulatory Filings
2020-08-20 English
Notice of Board Meeting
Regulatory Filings
2020-08-17 English
Positive Profit Alert
Regulatory Filings
2020-08-13 English
Voluntary Announcement - Nadroparin Calcium for Injection obtained Drug Registration Approval
Regulatory Filings
2020-08-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020
Major Shareholding Notification
2020-08-03 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-07-17 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-07-17 English
Voluntary Announcement - Update on the Introduction and Research and Development of an Investigational Oncology Product
Regulatory Filings
2020-07-16 English
Environmental, Social and Governance Report 2019
Environmental & Social Information
2020-07-15 English
Voluntary Announcement - Update on an Investigational Inhaled Antipsychotic Product
Regulatory Filings
2020-07-13 English
Voluntary Announcement - Possible Spin-off and Separate Listing of China Ophthalmology Focus Limited
Capital/Financing Update
2020-07-09 English
Voluntary Announcement - Update on the In-Licensing and Research and Development of Ophthalmology Products
Capital/Financing Update
2020-07-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
Share Issue/Capital Change
2020-07-02 English
Voluntary Announcement - Unidrox Prulifloxacin Tablet Obtained Imported Drug License from China's National Medical Products Administration
Regulatory Filings
2020-06-26 English
Voluntary Announcement - Update on an Investigational Dermatology Product
Regulatory Filings
2020-06-22 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-06-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Share Issue/Capital Change
2020-06-01 English
First Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-06-01 English
First Quarterly Results Announcement for the Three Months Ended 31 March 2020
Interim / Quarterly Report Q1 2020
2020-05-26 English
Annual General Meeting Held on 21 May 2020 - Poll Results
Declaration of Voting Results & Voting Rights Announcements
2020-05-21 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-05-18 English
Notice of Board Meeting
Regulatory Filings
2020-05-14 English
Voluntary Announcement - Update on an Investigational Inhaled Antipsychotic Product
Regulatory Filings
2020-05-12 English
Voluntary Announcement - Update on an Investigational Oncology Product
Regulatory Filings
2020-05-08 English
Voluntary Announcement - Update on the In-Licensing and Research and Development of Ophthalmology Products
Capital/Financing Update
2020-05-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Capital/Financing Update
2020-05-04 English
Proxy Form
Proxy Solicitation & Information Statement
2020-04-17 English
Notice of Annual General Meeting
AGM Information
2020-04-17 English
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, and Notice of Annual General Meeting
AGM Information
2020-04-17 English
Annual Report 2019
Annual Report FY 2019
2020-04-17 English
Grant of Share Options
Transaction in Own Shares
2020-04-15 English
Voluntary Announcement - Appointment of Chief Strategy Officer specialising in Ophthalmology
Board/Management Information
2020-04-14 English
Voluntary Announcement - Update on an Investigational Dermatology Product
Regulatory Filings
2020-04-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
Capital/Financing Update
2020-04-01 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-03-27 English
Announcement of Annual Results for the year ended 31 December 2019
Annual Report FY 2019
2020-03-26 English
Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-03-24 English
Voluntary Announcement - Treprostinil Injection Obtained Approval for Drug Registration
Regulatory Filings
2020-03-19 English
Voluntary Announcement - Update on an Inhalation Gas Product
Regulatory Filings
2020-03-16 English
Profit Warning
Regulatory Filings
2020-03-16 English
Notice of Board Meeting
Board/Management Information
2020-03-16 English
Voluntary Announcement - Aliskiren Combined with Nifedipine Obtained Approval from West China Hospital Biomedical Ethics Committee of Sichuan University to Conduct Clinical Trial on the Treatment of H
Regulatory Filings
2020-03-10 English
Voluntary Announcement - Business Update of an Associated Company of the Group
Regulatory Filings
2020-03-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
Capital/Financing Update
2020-03-02 English
Connected Transaction - Subscription for Shares in a Connected Subsidiary
Capital/Financing Update
2020-02-13 English
Continuing Connected Transaction - Provision of Financial Assistance
Capital/Financing Update
2020-02-11 English
VOLUNTARY ANNOUNCEMENT - UPDATE OF BUSINESS DEVELOPMENT WITH ITALFARMACO
Regulatory Filings
2020-02-06 English
Voluntary Announcement - Update on Business Development
Regulatory Filings
2020-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
Capital/Financing Update
2020-02-03 English
Voluntary Announcement - Update on an Investigational Ophthalmology Product
Regulatory Filings
2020-01-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
Share Issue/Capital Change
2020-01-02 English